Thermo Fisher Scientific expands its cell therapy development and manufacturing capabilities with new facility in San Francisco, CA.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Midsize pharma company stabilizes API - Accelerates time to clinic from three months to three weeks
Case study
A midsize pharma company wanted to progress its therapy from early development to late-phase clinical trial stage, but needed a CDMO partner to provide support in formulation analysis so that it could stabilize its product and successfully reach its clinical studies milestones.